A distal effect of microsomal triglyceride transfer protein deficiency on the lysosomal recycling of CD1d by Sagiv, Yuval et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
ARTICLE
JEM © The Rockefeller University Press  $15.00
Vol. 204, No. 4,  April 16, 2007  921–928  www.jem.org/cgi/doi/10.1084/jem.20061568
921
The CD1 family of glycoproteins is composed 
of conserved MHC-like, β2-microglobulin–
associated glycoproteins that specialize in the 
capture of self and microbial lipid antigens for 
presentation to T cells (1, 2). Recent studies 
have revealed that CD1-mediated antigen 
presentation depended on a set of proteins 
involved in general lipid metabolism. Thus, 
lysosomal saposins, which promote the enzy-
matic degradation of glycosphingolipids (GSLs), 
also performed essential lipid exchange reac-
tions between membranes and CD1 proteins 
(3–5). CD1e, a lysosomal member of the human 
CD1 family, enhanced lipid processing by 
  degrading enzymes (6). Serum VLDL and the 
surface LDL receptor directly contributed to the 
transport and uptake of exogenous   lipids (7). 
Disruption of NPC1, a transmembrane protein 
present in late endosomal membranes, inter-
rupted GSL traffi   cking from late endosome to 
lysosome and impaired CD1-mediated   antigen 
presentation and NKT cell development (8).
Several lines of evidence also suggest a role 
for microsomal triglyceride transfer protein 
(MTP), an ER-resident protein that functions 
as a lipid transfer protein and is essential for 
the loading of apolipoprotein B (apoB) with 
cholesterol, triacylglycerol, and phospholipids (9). 
MTP was originally characterized as a het-
erodimer of protein disulfi  de isomerase and a 
97-kD subunit in the ER of hepatocytes and 
enterocytes (10–12), but recent studies have 
demonstrated weak expression in hemopoietic 
cells as well, including T cells and dendritic cells 
(13). Because MTP coprecipitated with CD1d 
and could transfer lipids onto plate-bound 
CD1d in a cell-free assay, it was proposed that 
MTP might assist in loading lipids onto CD1 
molecules during biosynthesis in the ER in a 
manner similar to chaperone-assisted loading of 
peptides onto nascent MHC class I molecules 
(13, 14). In the absence of MTP, misfolded 
CD1d molecules would be retained in the ER, 
explaining the reduction of surface CD1d and 
the impaired antigen presentation observed 
in MTP-defi  cient cells. Consistent with this 
hypothesis, MTP ablation after injection of 
double-stranded RNA (dsRNA [polyI:C]) in 
mttpfl  /fl   Mx1-Cre mice aff   orded resistance to 
diseases mediated by CD1d-restricted NKT 
cells such as αGalCer-induced hepatitis and 
oxazolone-induced colitis (14).
Here, we have examined the presentation 
of lipid antigens and studied the dynamics of 
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the cellular traffi   cking of CD1d and lipids in cells lacking 
MTP. Severe defects in lipid antigen presentation were 
observed, but, surprisingly, they appeared to be selective for 
lipid antigens requiring lysosomal processing or loading rather 
than those acquired in the secretory pathway. In addition, 
cell biological assays revealed that MTP defi  ciency selectively 
impaired CD1d traffi   cking  between  the lysosome and the 
plasma membrane, far from the proposed site of action during 
biosynthesis in the ER. Consistent with these fi  ndings, the 
development of Vα14-Jα18 NKT cells, which requires lyso-
somal loading of natural ligands, was partially impaired in 
radiation chimeras reconstituted with MTP-defi  cient bone 
marrow cells. These intriguing fi  ndings converge to defi  ne a 
novel MTP-regulated mechanism that controls an essential 
step in the presentation of many lipid antigens, the recycling 
of CD1d from the lysosome to the plasma membrane.
RESULTS
MTP ablation impairs V𝗂14 NKT cell development
Because expression of CD1d by cortical thymocytes is es-
sential for the development of Vα14 NKT cell, we crossed 
mttpfl  /fl   mice to mice expressing the pLck-Cre transgene ex-
pressed in thymocytes. Genomic typing of WT and mttpfl  /fl   
mice is shown in Fig. 1 A. Despite  95% genetic ablation of 
the fl  oxed mttp gene segment (Fig. 1 B), the frequencies of 
Vα14 NKT cells in thymus and spleen were not signifi  cantly 
diminished (Fig. 1 C). As an assay to probe for NKT ligand 
expression by thymocytes, we measured IL-2 release after 
  exposure of NKT hybridomas to MTP-defi  cient thymocytes. 
Despite the absence of NKT cells’ developmental defect, the 
response of the Vα14 hybridoma DN32.D3 was reduced, 
whereas, in contrast, the non-Vα14 hybridoma TCB11 was 
unaff  ected (Fig. 1 D). These hybridomas are widely used to 
probe for endogenous ligands acquired in the lysosomal versus 
the secretory pathway, respectively. Thus, DN32.D3 responds 
to iGb3 loaded onto CD1d by saposins in the lysosome, 
whereas TCB11 responds to an unidentifi  ed ligand loaded in 
the secretory pathway. Because the ablation of mttp was 
  incomplete and low residual ligand expression could explain 
conserved NKT cell development in vivo, we crossed mttpfl  /fl   
mice to mice expressing the Cre recombinase under control 
of the IFN-inducible Mx1 promoter. Bone marrow cells 
from mttpfl  /fl   Mx1-Cre (fl  /fl  -Mx1Cre) and WT (nonfl  oxed 
mttp) littermates treated with multiple injections of dsRNA 
(polyI:C) were used to reconstitute lethally irradiated 
CD1d−/− hosts. This procedure achieved 99.6% deletion of 
mttp in the bone marrow (Fig. 2 A). In this system, Vα14 
NKT cells were modestly reduced by 50–60% both in the 
thymus and the spleen, whereas B cells and CD4 and CD8 
T cells were preserved (Fig. 2, B and C). To test whether the 
Figure 1.  Impaired stimulation of V𝗂14-J𝗂18 NKT cells by mttpfl  /fl   
Lck-Cre thymocytes. (A) Genomic DNA typing of WT, mttpfl  /fl  , and 
heterozygous mice. (B) Semiquantitative PCR of genomic mttp and gapdh 
in thymocytes and sorted splenic B cells. (C) Vα14-Jα18 NKT cells in the 
thymus (T) and spleen (S) as determined by CD1d-αGalCer tetramer 
staining. Frequency of Vα14-Jα18 NKT cells are indicated as a percentage 
of mttpfl  /fl   Lck-Cre over WT littermates. (D) IL-2 response of the Vα14-
Jα18 NKT hybridoma DN32.D3 and the non-Vα14 hybridoma TCB11 stim-
ulated by fresh thymocytes of WT and mttpfl  /fl   Lck-Cre littermates as 
indicated. Mean ± SD of two individual thymuses is shown; data are 
representative of two independent experiments.
Figure 2.  mttpfl  /fl   Mx1-Cre bone-marrow reconstituted chimeras. 
Lethally irradiated CD1d−/− mice were reconstituted with bone marrow 
(BM) cells from WT (nonfl  oxed mttp) and mttpfl  /fl   Mx1-Cre littermates 
treated with multiple injections of dsRNA (polyI:C; see Materials and 
methods). (A) Semiquantitative PCR of DNA levels for mttp and gapdh 
in bone marrow from WT and mttpfl  /fl   Mx1-Cre littermates treated with 
dsRNA (polyI:C). (B) Percentage of Vα14-Jα18 NKT cells (gated as 
CD1d-αGalCer+B220low for splenocytes and CD1d-αGalCer+CD24low for 
thymocytes) in chimeras reconstituted with WT or mttpfl  /fl   Mx1-Cre BM. 
A CD1d−/− mouse is shown as control. (C) Vα14-Jα18 NKT cells, CD4 
and CD8 T cells, and B cell frequencies in chimeras reconstituted with 
mttpfl  /fl   Mx1-Cre bone marrow shown as a percentage of cell frequen-
cies in chimeras reconstituted with WT BM. **, P < 0.05. (D) Mixed 
  chimeras reconstituted with WT and MTP-defi  cient BM (1:1). Summary 
plot showing individual frequencies of MTP-defi  cient NKT, CD4, CD8, 
and B cells as a percentage of the total. (E) CD1d surface expression in 
CD4+CD8+   double-positive thymocytes from chimeras reconstituted 
with WT, MTP-defi  cient, or mixed BM. Data are representative of three 
independent experiments.JEM VOL. 204, April 16, 2007  923
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requirement of MTP was intrinsic to the developing NKT 
cells or to the CD1d-presenting cells, we generated mixed 
bone marrow chimeras by mixing bone marrow from Ly5.1 
WT mice and from dsRNA (polyI:C)–injected fl  /fl  -Mx1Cre 
mice (Ly5.2). Although the overall hemopoietic reconstitu-
tion by MTP-defi  cient bone marrow cells was less effi   cient 
than WT, NKT cell development was unaff  ected relative to 
other lymphocyte compartments, including CD4 and CD8 
T cells and B cells (Fig. 2 D). Considering the conserved 
level of CD1d expression (Fig. 2 E), these results are consis-
tent with a selective defect in lipid ligand presentation by 
CD1d-expressing thymocytes as a mechanism for the 
  decreased   frequency of NKT cells.
Selective defect in lysosomal-dependent lipid 
antigen presentation
To investigate the functional and cell biological defects of 
CD1d-mediated lipid antigen presentation in cells lacking 
MTP, we used small interfering RNA (siRNA) to knock 
down (KD) the mttp mRNA in the rat basophilic leukemia 
(RBL) cell line transfected with CD1d. Diff  erent  siRNA 
were designed to generate several stable clones expressing 
various levels of residual mRNA (Fig. 3 A). Clones 3-9 and 
20-1 expressing <20% residual MTP lost the ability to stim-
ulate 2/2 Vα14 NKT hybridomas, DN32.D3 and N383c 
(Fig. 3 B). Clone 4-6, with only an  50% reduction of MTP 
mRNA, exhibited only a modest defect in stimulation. Nota-
bly, stimulation of 3/3 non-Vα14 NKT hybridomas, TCB11, 
TBA7, and 1C8DC1, remained intact (Fig. 3 B). These selec-
tive defects match the well-established dichotomy between 
Vα14 and non-Vα14 NKT hybridomas with respect to their 
recognition of endosomal and nonendosomal ligands, respec-
tively. They do not seem consistent, however, with the model 
suggesting that MTP critically regulates CD1d biosynthesis in 
the ER. Surface staining of CD1d in MTP-defi  cient clones 
showed a twofold reduction compared with the parental 
clone. Although these diff  erences may be accounted for by 
interclonal variations, it is notable that the intracellular levels 
of CD1d were conserved or increased compared with WT. 
Thus, the intracellular/surface ratio was increased three- to 
fourfold in MTP KD cells, suggesting intracellular retention 
(Fig. 3 C). Notably, sorted RBL-CD1d cells expressing low 
levels of surface CD1d stimulated DN32.D3 well above the 
MTP-defi  cient RBL-CD1d clones, which express an inter-
mediate level of surface CD1d, whereas stimulation of TBA7 
was not altered by the absence of MTP (Fig. 3 D). Thus, a 
lower level of surface CD1d expression is unlikely to explain 
the selective Vα14 NKT cell stimulation defect.
Additional antigen presentation experiments were per-
formed using a battery of well-defi  ned synthetic GSL anti-
gens (Fig. 4). The MTP KD clone 3-9 exhibited a partial 
defect in the presentation of αGC, which is known to   depend 
on lysosomal loading, at least partially, for recognition by 
Vα14 NKT cells. The two disaccharide GSLs, α 1,2 α 
GalCer (PBS18) and α 1,4 α GalCer (PBS19), require lyso-
somal removal of the outer galactose before recognition by 
NKT cells. These two compounds were very poorly pre-
sented by the MTP KD clones, even at the highest concen-
trations. In addition, we found a profound defect in the 
presentation of exogenously added iGb3 or its precursor 
iGb4, both of which are also highly dependent on lysosomal 
traffi   cking of CD1d.
Conserved rate of CD1d biosynthesis and Golgi maturation
Because it is a direct prediction of the “ER chaperone” model 
that CD1d biosynthesis should be defective in the absence of 
MTP, we measured the rate of CD1d biosynthesis by immuno-
precipitating CD1d in [S35]cystein and methionine metabolic 
pulse-chase experiments. As shown in Fig. 5 A, there was no 
signifi  cant decrease in the rate of biosynthesis or the rate of 
acquisition of Endo-H resistance, indicating intact ER synthesis 
and Golgi maturation of CD1d in the absence of MTP.
Figure 3.  MTP-defi  cient RBL-CD1d cells fail to stimulate V𝗂14-
J𝗂18 NKT cells. (A) Various siRNA were stably expressed to generate 
MTP-defi  cient clones in RBL-CD1d cells. (left) Semiquantitative RT-PCR 
levels of mttp and gapdh; (right) bar graph display of residual mttp mRNA 
in individual MTP KD clones. (B) Stimulation of Vα14-Jα18 NKT hybrido-
mas (DN32.D3 and N383C) and non-Vα14-Jα18 NKT hybridomas (TCB11, 
TBA7, and 1C8DC1) by individual siRNA MTP KD clones. Clone MTP 4-6 
expressed 50% of the original mRNA levels of mttp, whereas clones 3-9 
and 20-1 expressed <20%. RBL cells expressing neither CD1d (RBL) nor 
siRNA (RBL-CD1d) were used as controls. Data are representative of three 
independent experiments. (C) Surface and intracellular levels of CD1d 
were detected by fl  ow cytometry using FITC- and PE-conjugated CD1d 
antibodies before and after permeabilization, respectively. The ratio 
  between intracellular and surface CD1d (I/S) is shown for each clone. 
(D) Stimulation of Vα14-Jα18 NKT hybridoma (DN32.D3) and non–Vα14-
Jα18 NKT hybridoma (TCB11) by RBL-CD1d cells, sorted RBL-CD1d cells 
expressing low levels of CD1d, and by siRNA MTP KD clones. Mean fl  uo-
rescence intensity of CD1d surface levels are indicated below the graph.924  MTP DEFICIENCY AND LIPID ANTIGEN PRESENTATION | Sagiv et al.
Defective recycling of CD1d from lysosome 
to plasma membrane
Altogether, our data suggested preservation of the secretory 
pathway and pointed to the lysosomal compartment as the 
site of impact of MTP defi  ciency. Using surface and intra-
cellular fl  ow cytometry staining for CD1d in MTP mutant 
and wild-type cells, we observed a conspicuous and consistent 
three- to fourfold increase of the intracellular over surface 
  ratio of CD1d in MTP-defi  cient clones (Fig. 3 C). CD1d 
  accesses the plasma membrane at two diff  erent stages of its life 
cycle: early, after biosynthesis by export from the ER via the 
Golgi to the cell surface, and late, after internalization from 
the plasma membrane to endosomal compartments from 
which CD1d recycles back and forth to the plasma mem-
brane. Thus, the association of conserved synthesis and accu-
mulation in late endosomal/lysosomal compartments (see 
below) suggested alterations in the late internalization/recycling 
events between plasma membrane and lysosome. Direct 
  measurements of internalization rates using a surface biotinyl-
ation assay with cleavable biotin (15) unambiguously estab-
lished that the rate of internalization was preserved in 
MTP-defi  cient cells (Fig. 5 B, left). Another assay based on 
surface staining with biotinylated anti-CD1d antibodies 
yielded identical results (Fig. 5 B, right). Altogether, the data 
pointed to a defect in the recycling of CD1d from internal 
late endosomal/lysosomal stores to the plasma membrane. 
We thus extended the surface biotinylation assay to follow 
the surface reexpression of a cohort of CD1d molecules that 
were previously internalized over a prolonged 7-h period to 
ensure traffi   cking to the lysosome. Cleavage of surface biotin 
was followed by a 4-h period of incubation, and a second 
cleavage removed the biotin associated with surface reexpres-
sion of CD1d. In the WT clone, the amount of intracellular 
biotinylated CD1d was reduced by >50% between strips 
I and II, demonstrating active recycling to the surface. In sharp 
contrast, the MTP KD clone 3-9 did not show recycling 
from intracellular compartments to the surface, as demon-
strated by the lack of reduction of intracellular CD1d-biotin 
between strips I and II (Fig. 5 C). In fact, even the  30% 
  reduction normally seen after strip I could not be observed, 
likely refl  ecting the progressive lysosomal accumulation over 
the initial 7-h period. Similar results were found with another 
MTP KD clone, 20-1 (unpublished data). Impaired CD1d 
recycling from lysosomes to the cell surface is suffi   cient to 
explain the selective presentation defect for lipid antigens that 
require CD1d traffi   cking to the lysosomes as well as the 
  decreased surface expression of CD1d.
Other lysosomal functions
Lysosomal dysfunction has not been previously observed in 
MTP-defi  cient cells. Confocal analysis showed normal gross 
morphology of the LAMP1+ late endosomal/lysosomal 
compartment of MTP-defi  cient cells and normal localization 
of the majority of intracellular CD1d in this compartment 
(Fig. 6 A, left). However, because some LAMP-1+ vesicles 
appeared to be larger in MTP-defi  cient than in WT cells, 
we performed a FACS quantifi  cation of the Lysotracker+ 
Figure 4.  Defective lipid antigen presentation by MTP-defi  cient 
RBL-CD1d cells. The Vα14-Jα18 NKT cell hybridoma (DN32.D3) was 
stimulated by various lipids, as indicated, in the presence of RBL-CD1d 
cells, MTP KD clone 3-9, and cells that do not express CD1d (RBL). PBS18: 
Gal α 1,2 α GalCer; PBS19: Gal α 1,4 α GalCer; iGb3: Gal α 1,3 Gal β 1,4 
Glc β 1,1 Cer; iGb4: GalNAc β 1,3 Gal α 1,3 Gal β 1,4 Glc β 1,1 Cer.
Figure 5.  Biochemical studies of CD1d traffi  cking. (A) [S35]methionine 
and cysteine pulse-chase analysis of CD1d biosynthesis. (left) CD1d mol-
ecules were immunoprecipitated with the 20H2 antibody, and samples 
were treated or not with Endo-H, before SDS-PAGE and detection with a 
phosphorimager. Data are representative of three independent experi-
ments. (right) Data pooled from two kinetic experiments are shown as 
percentage Endo-H sensitive (100× sensitive/[resistant + sensitive]). 
(B) CD1d internalization. Data are representative of three independent 
experiments. (C) Recycling of CD1d. Residual intracellular biotinylated 
CD1d after fi  rst stripping (internalization) and second stripping (recycling). 
See Materials and methods. Mean + SD of triplicate samples is shown; 
data are representative of three independent experiments.JEM VOL. 204, April 16, 2007  925
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compartment and detected a 1.7- to twofold increase in the 
staining intensity of MTP-defi  cient cells in two separate ex-
periments (Fig. 6 A, right). In a previous report, chemical in-
hibition of MTP did not impair presentation of ovalbumin to 
MHC class II–restricted peptide–specifi  c OTII CD4 T cells. 
We   directly confi  rmed that lysosomal degradation of hen egg 
lyzozyme (HEL) and horse radish peroxidase (HRP) pro-
ceeded with normal kinetics in the absence of MTP (Fig. 6 B). 
In addition, we studied the traffi   cking of exogenously admin-
istered PBS10, a fl   uorescent version of αGC tagged with 
prodan on C6” (16), and demonstrated normal traffi   cking to 
the late endosome and the lysosome (Fig. 6 C, left). How-
ever, another fl  uorescently labeled lipid, BODIPY-  LacCer, 
which is known to accumulate in the Golgi after vesicular 
transport from the plasma membrane to the late endosome to 
the ER, showed abnormal retention in the Lysotracker+ 
compartment (Fig. 6 C, top right), suggesting the existence 
of at least some lipid traffi   cking defects in MTP-defi  cient 
cells. NBD-ceramide (Fig. 6 C, bottom right), which is 
  rapidly transported from the plasma membrane to the ER by 
a nonendocytic pathway and then transferred to the Golgi by 
the cytosolic transporter CERT (ceramide transfer protein; 
reference 17), reached its destination normally in the ab-
sence of MTP. In an attempt to detect additional defects in 
  lysosome-to-surface traffi   cking, we studied serotonin secre-
tion, which occurs by granule exocytosis after exposure of 
RBL mast cells to IgE–DNP immune complexes (18). Fig. 6 D 
shows that Fc receptor–triggered serotonin secretion was 
conserved in MTP-defi   cient RBL cells. Altogether, these 
  results suggest the existence of partial and selective lysosomal 
defects associated with MTP defi  ciency, including an increase 
in the overall size of the lysosomal compartment and an 
  abnormal lysosomal retention of the lipid BODIPY-LacCer.
D  I  S  C  U  S  S  I  O  N 
Although several proteins involved in the uptake, exchange, 
or transmembrane transport of lipids have been clearly in-
volved in various aspects of CD1-mediated antigen presenta-
tion (3–8), the recently reported role of MTP remains 
somewhat elusive. The ER location of MTP, its coprecipita-
tion with CD1d, and its well-established function in loading 
apoB with lipids have suggested that MTP might be a chap-
erone assisting the folding of nascent CD1d proteins through 
lipid loading. Indeed, chaperone-assisted folding and peptide 
loading are essential for MHC molecules, and it is logical to 
postulate that similar mechanisms might be associated with 
CD1 biosynthesis. However, some of the reported functional 
consequences of the genetic ablation or chemical inhibition 
of MTP were not fully consistent with this proposed func-
tion. For example, the decrease in CD1d surface expression 
was often modest and could not alone explain the profound 
defects in lipid antigen presentation seen upon genetic abla-
tion of mttp (14). Likewise, chemical inhibition of MTP in 
two diff  erent human cell lines led to a defect in NKT cell 
stimulation without notable decrease in surface CD1d levels 
(13). In addition, when localization of CD1d was studied by 
confocal microscopy of liver sections, a majority of CD1d 
molecules were outside the ER, whether or not MTP was 
inactivated (14). Finally, although purifi  ed MTP could trans-
fer phosphatidylethanolamine onto plastic wells coated with 
CD1d, the lipid transfer assay was indirect, and the stoichio-
metry of CD1d loading was not determined (13). Whether, 
like the well-studied saposins (3, 4), MTP can effi   ciently 
transfer lipids onto CD1d remains unclear.
We present direct cell biological and functional evidence 
suggesting an alternative explanation for the CD1d-mediated 
lipid presentation defects of MTP-defi  cient cells. Metabolic 
pulse-chase radiolabeling experiments established that the 
rates of CD1d biosynthesis and transit through ER and Golgi 
Figure 6.  Lysosomal functions of MTP KD clones. (A, left) Confocal 
microscopy analysis of RBL-CD1d and MTP KD 3-9 cells costained with 
LAMP1 (green) and CD1d (red). Bar, 18 μm. (right) Lysotracker staining 
fl  uorescence intensity of RBL-CD1d and its MTP KD variant MTP 3-9. Con-
trol indicates unstained RBL cells. The mean fl  uorescence intensity of MTP 
3–9 was increased 1.7- to twofold over WT in two separate experiments. 
(B) Kinetics of HEL (left) and HRP (right) degradation, measured by West-
ern blot or intracellular fl  ow cytometry, respectively. Data are representa-
tive of two independent experiments. (C) Intracellular traffi  cking of 
exogenously administered lipids. (left, top) PBS10 (green) traffi  cking to 
the LAMP1+ compartment (red); (bottom) colocalization of PBS10 (green) 
and Lysotracker (red). (right, top) Lysosomal retention of BODIPY-LacCer 
in MTP 3-9 cells, shown by partial colocalization with Lysotracker; (bot-
tom) conserved traffi  cking of NBD-Ceramide to the Golgi apparatus in 
MTP 3-9 cells. Bar, 8 μm. (D) [3H]serotonin release by Fc receptor–
activated RBL-CD1d and MTP KD 3-9 cells. Mean + SD of triplicates 
wells is shown; data are representative of two independent experiments.926  MTP DEFICIENCY AND LIPID ANTIGEN PRESENTATION | Sagiv et al.
were unaltered in the absence of MTP. In addition, using a 
panel of well-characterized NKT hybridomas reactive to 
endogenous lipids, we found that, in the absence of MTP, 
CD1d-expressing cells stimulated the hybridomas responding 
to endogenous lipids loaded in the secretory compartment, 
whereas, in sharp contrast, they failed to stimulate those rec-
ognizing lysosomal antigens such as iGb3. Consistent with 
these in vitro fi  ndings, NKT cell development and stimula-
tion by thymocytes were partially impaired in vivo in chime-
ric mice carrying a deletion of the fi  rst exon of MTP in their 
cortical thymocytes.
These surprising fi  ndings led us to consider the lysosomal 
stage of CD1d traffi   cking as a potential target of MTP. Previ-
ous studies have shown that, at steady state, most of the CD1d 
molecules normally reside in the lysosomal compartment, 
from which they undergo prolonged recycling back and forth 
to the plasma membrane. This movement is governed by a 
tyrosine motif in the intracytoplasmic tail of CD1d that binds 
AP-2 and AP-3 (19–21). CD1d tail-truncated mutants fail to 
present many lipids, including the Vα14 NKT ligand iGb3, 
or the di- or triglycosylated derivatives of αGalCer that re-
quire processing by lysosomal glycosidases before recognition 
by Vα14 NKT cells. Thus, the functional defects associated 
with the tail truncation of CD1d resemble those associated 
with MTP defi  ciency.
The intracellular distribution patterns, however, are op-
posite. Whereas tail-truncated CD1d exhibits a higher level 
of surface expression and decreased intracellular accumulation, 
the intracellular/surface ratio is increased in MTP-  defi  cient 
cells. Importantly, the intracellular site of accumulation is the 
late endosome/lysosome rather than the ER. Thus, the con-
served internalization rate and markedly decreased recycling 
identify a block in the exit pathway that normally allows 
CD1d molecules to return to the plasma membrane after 
they have loaded lipid antigens in the lysosome. This anomaly 
provides a potential explanation for all the cell biological and 
functional changes of CD1d traffi   cking and antigen presenta-
tion observed in MTP-defi  cient cells or animals. Because 
  little is known about the molecular mechanisms controlling 
recycling in normal cells, there is at present no clear sugges-
tion as to the precise molecular target of MTP. Reports that 
MHC class II presentation is conserved in MTP-defi  cient 
cells and our own fi  ndings that lysosomal degradation of HEL 
and HRP proteins are unaltered, that PBS10, a fl  uorescently 
labeled αGC, traffi   cs normally to late endosome and lyso-
some, and that granule exocytosis is conserved in the absence 
of MTP suggest that the lysosomal defects are relatively selec-
tive. However, the size of the Lysotracker+ compartment 
appeared to be signifi  cantly increased, and a lysosomal reten-
tion of BODIPY-LacCer, which normally reaches the Golgi af-
ter endocytosis to the late endosome, could be detected as well. 
Thus, changes in the lipid composition of some membranes 
or lipid storage may alter the dynamics of the CD1d recycling 
pathway. Alternatively, MTP defi  ciency may impact another 
unidentifi  ed protein involved in recycling. Notably, recent 
experiments investigating CD1d-mediated lipid presentation 
defects associated with herpes simplex virus-1 infection have 
uncovered a very similar dysregulation of CD1d recycling 
from lysosome to plasma membrane (22), revealing the 
importance of this previously overlooked stage of CD1d 
traffi   cking and suggesting its relevance in host defense.
Our results do not rule out the possibility that, in the 
  absence of MTP, aberrant lipid loading in the ER might 
  prevent subsequent exchange with other lipid ligands in the 
lysosome and somehow alter CD1d recycling. This hypo-
thesis, however, remains to be tested. Furthermore, although 
we found that 3/3 non-Vα14 autoreactive hybridomas 
  (previously shown to respond to endogenous ligand loaded 
independently of lysosomal traffi   cking of CD1d) recognized 
CD1d in the absence of MTP, the response of another non-
Vα14 hybridoma, 14S6, was reported to be altered (13), 
  suggesting that, in addition to the major lysosomal defects, 
lipid presentation in the secretory pathway might be partially 
impaired as well.
In conclusion, MTP defi  ciency induces severe defects of 
lipid antigen presentation by CD1d. Despite the ER loca-
tion of MTP, convergent cell biological and functional ex-
periments indicate that a major impact on CD1d-mediated 
antigen presentation is in the altered recycling of CD1d from 
the lysosome to the plasma membrane. This surprising fi  nd-
ing reveals a previously ignored, long-range eff  ect of MTP 
in an important, yet poorly understood, intracellular traffi   ck-
ing process.
MATERIALS AND METHODS
Mice. Mice with a “fl  oxed” Mttp allele on a mixed C57BL/6 and 129S4/
SvJae background (B6;129S-Mttptm2Sgy/J) were from The Jackson laboratory. 
These mice were bred with mice transgenic for Mx1 or Lck promoter-
driven Cre recombinase on a C57BL/6 background (The Jackson Labora-
tory). Littermates were typed to determine Cre and fl  oxed mttp presence by 
PCR according to a published protocol (23). The primer sequences used for 
mttp typing were 5′-G  C  T  C  T  C  A  A  G  A  G  G  A  G  G  T  T  A  A  G  G  -3′ and 5′-C  G  T-
C  T  T  T  C  A  A  G  A  G  A  A  T  G  C  C  C  -3′. Detection of Mx1 or Lck Cre by PCR 
was done as described (The Jackson Laboratory). MTP-defi  cient mice and 
their WT littermates (nonfl  oxed mttp mice with or without Cre) were used 
for comparative analysis. CD1 KO mice in the C57BL/6 background were 
generated and maintained as described previously (24). All mice were raised 
in a specifi  c pathogen-free environment at the University of Chicago, 
according to the Institutional Animal Care and Use Committee guidelines.
Bone marrow radiation chimeras. C57BL/6 CD1 KO mice received 
whole-body γ-irradiation (1,000 rad) with a cesium source (Gammacell 40; 
MDS Nordion) and were reconstituted 6 h later with one i.v. injection of 
10 × 106 bone marrow cells from various adult donors as described. Mttpfl  /fl   
Mx1-Cre mice and WT littermates were treated intraperitoneally with 400 μg 
dsRNA (polyI:C; Sigma-Aldrich) in PBS every day for 6 d, before bone 
marrow was collected and injected into irradiated CD1 KO mice.
Cell culture. Fresh thymocytes and splenocytes were obtained as described 
previously (25). Stably CD1d transfected RBL cells (25) were transfected 
with the vector pSUPER to form stable MTP KD siRNA clones (26), 
using selected sequences from the Rat mttp gene. The sequences used for 
the siRNA constructs were 5′-C  C  T  C  T  G  G  A  A  C  C  A  C  C  A  A  T  G  A  -3′ for 
clone 4-6, 5′-T  T  G  C  A  G  C  C  A  C  T  C  C  A  G  A  T  G  A  -3′ for clone 20-1, and 
5′-C  T  T  G  G  A  G  G  C  T  C  T  A  C  G  G  A  G  A  -3′ for clone 3-9. Clones were se-
lected with 12.5 μg/ml puromycine, and MTP mRNA levels were detected 
by RT-PCR (CLONTECH Laboratories, Inc.). The sense and antisense JEM VOL. 204, April 16, 2007  927
ARTICLE
primers for Rat mttp were 5′-G  T  C  A  C  G  A  T  A  A  C  G  G  C  T  G  T  C  A  A  T  G  T  C  -3′ 
and 5′-C  C  T  C  T  C  A  A  T  T  T  T  G  C  A  T  G  T  A  T  C  C  A  G  -3′, respectively. For rat 
gapdh, primers were 5′-C  T  C  T  G  G  A  A  A  G  C  T  G  T  G  G  C  G  T  G  A  T  G  G  -3′ and 
5′-C  T  G  T  A  G  C  C  A  T  A  T  T  C  A  T  T  G  T  C  A  T  A  C  C  -3′.
Pulse-chase labeling. Experiments were done as described previously (15). 
In brief, to study the biosynthesis and traffi   cking rate of CD1d from ER to 
the Golgi, cells were pulsed with 0.5 mCi/ml [S35]methionine and cystine 
(GE Healthcare) and chased with excess cold methionine and cysteine at 
37°C for the indicated times. Cells were harvested, and CD1d molecules 
were immunoprecipitated with 20H2 antibody. Samples were treated or 
  untreated with Endo-H according to the manufacturer’s instructions (New 
England Biolabs, Inc.), before running on SDS-PAGE gel and analysis 
by phosphorimager.
Biotin internalization and recycling assay. Assays were as described 
previously (15). In brief, for the biotin internalization assay, surface proteins 
were biotinylated with a cleavable biotin reagent, Sulfo-NHS-S-S-Biotin 
(Pierce Chemical Co.; 0.5 mg/ml in HBSS at 4°C for 15 min). Cells were 
then   incubated at 37°C for the indicated times, before stripping surface 
biotin with a glutathione solution. Levels of internalized CD1d molecules 
were detected by ELISA using 20H2 antibody to capture CD1d molecules 
and HRP-  conjugated streptavidin (R&D Systems) to detect biotin and 
quantifi   ed by reference to standard CD1d-biotin. Residual biotinylated 
CD1d was compared with total biotinylated CD1d at time 0 (before inter-
nalization). For the antibody internalization assay, cells were surface stained 
with biotinylated anti-CD1d antibody (clone 1B1; BD Biosciences), 
washed, and incubated at 37°C for the indicated times. Remaining surface 
CD1d molecules were detected by fl  ow cytometry using PE-conjugated 
streptavidin. For the recycling assay, surface proteins were biotinylated at 
4°C and cells were incubated for 7 h at 37°C. Residual surface biotin was 
stripped as described above and cells were incubated for 4 h to allow recy-
cling of internalized CD1d-biotin molecules to the surface. Surface biotin 
was stripped again, and residual biotinylated CD1d molecules were mea-
sured by ELISA as described.
Flow cytometry. CD1d-αGalCer tetramers were generated and used as 
described previously (27). FITC-conjugated anti-CD4, anti-CD1d, and 
anti-CD24; allophycocyanin-conjugated anti-B220; cychrome-conjugated 
anti-CD8; and PE-conjugated anti-CD1d were obtained from BD Bio-
sciences. For the detection of surface and intracellular CD1d levels, RBL 
cells were stained with saturating amounts of FITC-conjugated anti-CD1d 
before wash, fi  xation, and permeabilization (Cytofi  x/Cytoperm; BD Bio-
sciences) and staining with PE-conjugated anti-CD1d. Lysosomal staining 
was performed by incubating cells with LysotrackerRed DND99 (Invitrogen) 
at 1 μg/ml for 15 min. Flow cytometry was performed with FACSCalibur 
(Becton Dickinson), and data were analyzed using Cell Quest pro software 
(Becton Dickinson).
Protein degradation assay. 1 mg/ml HEL and HRP (Sigma-Aldrich) 
were incubated with RBL-CD1d and the MTP KD clone 3-9 for 4 h, 
  before the cells were washed and harvested at the indicated time points. 
  Residual protein levels were measured by Western blot for HEL (rabbit 
anti-lysozyme; ab391 [Abcam]) or intracellular fl  ow cytometry for HRP 
(mouse anti-HRP; ab8326 [Abcam]). Data are representative of two 
  independent experiments.
T cell hybridoma stimulation assay. NKT hybridomas, including the 
Vα14-Jα18 DN32.D3 (25) and N383C (28) and the non-Vα14-Jα18 
TCB11, TBA7, and 1C8DC1 clones (25), were incubated at 5 × 104 cells per 
96 fl  at microwell in the presence of 5 × 105 fresh thymocytes or 5 × 104 
RBL cells for 24 h in a 0.1-ml fi  nal volume of 1:1 mixture of Click’s medium 
and RPMI supplemented with 10% heat-inactivated FCS, glutamine, antibiotics, 
and 5 × 10−5 M 2-ME as described. IL-2 released in cultured supernatants 
was measured using CTLL-2 indicator cells as described previously (29).
[3H]serotonin release assay. Determination of [3H]serotonin release was as 
described previously (18). In brief, 2 × 105 RBL cells were incubated with 
0.4  μg/ml anti-DNP IgE (Sigma-Aldrich) in the presence of 2 μCi/ml 
[3H]serotonin (PerkinElmer) overnight. Cells were washed in modifi  ed 
  Tyrode’s buff  er (135 mM NaCl, 5 mM Kcl, 1 mM MgCl2, 1.8 mM CaCl2, 
5.6 mM dextrose, 10 mM Hepes, and 0.1% BSA) and activated at 37°C with 
500 μl modifi  ed   Tyrode’s buff  er containing 50 ng/ml DNP-HSA (Sigma-
  Aldrich) for 30 min. The reaction was stopped by placing the plate on ice 
and adding 500 μl of ice-cold modifi  ed Tyrode’s buff  er. Supernatant and 
cells were collected separately to measure serotonin release and uptake by the 
cells, respectively.
Confocal microscopy. To study lipid traffi   cking, cells were incubated 
with 0.5 μM BODIPY-LacCer (Invitrogen) or with 9 μM prodan-conjugated 
αGalCer (PBS10; reference 16) at 37°C for 1 h or overnight, respectively. 
Cells were stained with LysoTrackerRed DND99 (Invitrogen) at 0.25 μg/ml 
during the last 15 min and directly analyzed by confocal microscopy (with-
out fi  xation) or fi  xed before staining with rabbit anti-LAMP1 antibodies 
(ab24170; Abcam) and Cy5-conjugated donkey anti-rabbit antibodies 
  (Jackson ImmunoResearch Laboratories). To study ceramide traffi   cking, 
cells grown on coverslips were incubated with 5 μM NBD-Cer (Invitrogen) 
at 37°C for 5 min. Coverslips were washed in PBS, and samples were imme-
diately analyzed by confocal microscopy. FITC-conjugated rat anti-mouse 
LAMP1 antibodies (BD Biosciences) and biotin-conjugated anti-CD1d 
  antibodies (BD Biosciences) were used to stain LAMP1 and CD1d in RBL 
cells as described previously (3). Cells were examined by confocal micro-
scopy using a confocal microscope (TCS SP2 AOBS; Leica) with a 63× NA 
1.4 oil objective lens at room temperature.
The authors thank members of the Bendelac Laboratory for advice and support and 
Dr. Stefan Kraft for help with the serotonin release assay.
Y. Sagiv is supported by a fellowship from the Cancer Research Institute. This 
work was supported by National Institutes of Health grants to A. Bendelac, 
P.B. Savage, and L. Teyton (PO1 AI053725).
The authors have no confl  icting fi  nancial interests.
Submitted: 25 July 2006
Accepted: 14 March 2007
R  E  F  E  R  E  N  C  E  S 
 1. Brigl, M., and M.B. Brenner. 2004. CD1: antigen presentation and 
T cell function. Annu. Rev. Immunol. 22:817–890.
  2.  Park, S.H., and A. Bendelac. 2000. CD1-restricted T-cell responses and 
microbial infection. Nature. 406:788–792.
 3. Zhou, D., C. Cantu III, Y. Sagiv, N. Schrantz, A.B. Kulkarni, X. Qi, 
D.J. Mahuran, C.R. Morales, G.A. Grabowski, K. Benlagha, et al. 
2004. Editing of CD1d-bound lipid antigens by endosomal lipid transfer 
proteins. Science. 303:523–527.
 4. Kang, S.J., and P. Cresswell. 2004. Saposins facilitate CD1d-restricted 
pre  sentation  of an exogenous lipid antigen to T cells. Nat. Immunol. 
5:175–181.
 5. Winau, F., V. Schwierzeck, R. Hurwitz, N. Remmel, P.A. Sieling, 
R.L. Modlin, S.A. Porcelli, V. Brinkmann, M. Sugita, K. Sandhoff  , 
et al. 2004. Saposin C is required for lipid presentation by human CD1b. 
Nat. Immunol. 5:169–174.
 6. de la Salle, H., S. Mariotti, C. Angenieux, M. Gilleron, L.F. Garcia-
Alles, D. Malm, T. Berg, S. Paoletti, B. Maitre, L. Mourey, et al. 2005. 
Assistance of microbial glycolipid antigen processing by CD1e. Science. 
310:1321–1324.
 7. van den Elzen, P., S. Garg, L. Leon, M. Brigl, E.A. Leadbetter, J.E. 
Gumperz, C.C. Dascher, T.Y. Cheng, F.M. Sacks, P.A. Illarionov, 
et al. 2005. Apolipoprotein-mediated pathways of lipid antigen presen-
tation. Nature. 437:906–910.
  8.  Sagiv, Y., K. Hudspeth, J. Mattner, N. Schrantz, R.K. Stern, D. Zhou, 
P.B. Savage, L. Teyton, and A. Bendelac. 2006. Cutting edge: impaired 
glycosphingolipid traffi   cking and NKT cell development in mice lacking 
niemann-pick type c1 protein. J. Immunol. 177:26–30.928  MTP DEFICIENCY AND LIPID ANTIGEN PRESENTATION | Sagiv et al.
 9. White, D.A., A.J. Bennett, M.A. Billett, and A.M. Salter. 1998. 
The assembly of triacylglycerol-rich lipoproteins: an essential role 
for the   microsomal triacylglycerol transfer protein. Br. J. Nutr. 
80:219–229.
10.  Sharp, D., L. Blinderman, K.A. Combs, B. Kienzle, B. Ricci, K. Wager-
Smith, C.M. Gil, C.W. Turck, M.E. Bouma, D.J. Rader, et al. 1993. 
Cloning and gene defects in microsomal triglyceride transfer protein 
associated with abetalipoproteinaemia. Nature. 365:65–69.
11. Wetterau, J.R., and D.B. Zilversmit. 1986. Localization of intracel-
lular triacylglycerol and cholesteryl ester transfer activity in rat tissues. 
Biochim. Biophys. Acta. 875:610–617.
12. Wetterau, J.R., K.A. Combs, S.N. Spinner, and B.J. Joiner. 1990. 
Protein disulfi  de isomerase is a component of the microsomal triglyceride 
transfer protein complex. J. Biol. Chem. 265:9800–9807.
13. Dougan, S.K., A. Salas, P. Rava, A. Agyemang, A. Kaser, J. Morrison, 
A. Khurana, M. Kronenberg, C. Johnson, M. Exley, et al. 2005. 
Microsomal triglyceride transfer protein lipidation and control of CD1d 
on antigen-presenting cells. J. Exp. Med. 202:529–539.
14. Brozovic, S., T. Nagaishi, M. Yoshida, S. Betz, A. Salas, D. Chen, 
A. Kaser, J. Glickman, T. Kuo, A. Little, et al. 2004. CD1d function 
is regulated by microsomal triglyceride transfer protein. Nat. Med. 
10:535–539.
15. Jayawardena-Wolf, J., K. Benlagha, Y.H. Chiu, R. Mehr, and A. 
Bendelac. 2001. CD1d endosomal traffi   cking is independently regulated 
by an intrinsic CD1d-encoded tyrosine motif and by the invariant chain. 
Immunity. 15:897–908.
16. Zhou, X.T., C. Forestier, R.D. Goff  , C. Li, L. Teyton, A. Bendelac, 
and P.B. Savage. 2002. Synthesis and NKT cell stimulating properties 
of fl  uorophore- and biotin-appended 6”-amino-6”-deoxy-galactosylce-
ramides. Org. Lett. 4:1267–1270.
17. Hanada, K., K. Kumagai, S. Yasuda, Y. Miura, M. Kawano, M. 
Fukasawa, and M. Nishijima. 2003. Molecular machinery for non-
  vesicular traffi   cking of ceramide. Nature. 426:803–809.
18. Isersky, C., J.D. Taurog, G. Poy, and H. Metzger. 1978. Triggering 
of cultured neoplastic mast cells by antibodies to the receptor for IgE. 
J. Immunol. 121:549–558.
19. Sugita, M., X. Cao, G.F. Watts, R.A. Rogers, J.S. Bonifacino, and 
M.B. Brenner. 2002. Failure of traffi   cking and antigen presentation by 
CD1 in AP-3-defi  cient cells. Immunity. 16:697–706.
20.  Lawton, A.P., T.I. Prigozy, L. Brossay, B. Pei, A. Khurana, D. Martin, 
T. Zhu, K. Spate, M. Ozga, S. Honing, et al. 2005. The mouse CD1d 
cytoplasmic tail mediates CD1d traffi   cking and antigen presentation by 
adaptor protein 3-dependent and -independent mechanisms. J. Immunol. 
174:3179–3186.
21.  Elewaut, D., A.P. Lawton, N.A. Nagarajan, E. Maverakis, A. Khurana, 
S. Honing, C.A. Benedict, E. Sercarz, O. Bakke, M. Kronenberg, and 
T.I. Prigozy. 2003. The adaptor protein AP-3 is required for CD1d-
mediated antigen presentation of glycosphingolipids and development 
of Vα14i NKT cells. J. Exp. Med. 198:1133–1146.
22. Yuan, W., A. Dasgupta, and P. Cresswell. 2006. Herpes simplex virus 
evades natural killer T cell recognition by suppressing CD1d recycling. 
Nat. Immunol. 7:835–842.
23. Raabe, M., M.M. Veniant, M.A. Sullivan, C.H. Zlot, J. Bjorkegren, 
L.B. Nielsen, J.S. Wong, R.L. Hamilton, and S.G. Young. 1999. 
Analysis of the role of microsomal triglyceride transfer   protein 
in the liver of tissue-specific knockout mice. J. Clin. Invest. 103:
1287–1298.
24.  Park, S.H., D. Guy-Grand, F.A. Lemonnier, C.R. Wang, A. Bendelac, 
and B. Jabri. 1999. Selection and expansion of CD8α/α+ T cell receptor 
α/β+ intestinal intraepithelial lymphocytes in the absence of both 
  classical major histocompatibility complex class I and nonclassical CD1 
molecules. J. Exp. Med. 190:885–890.
25. Chiu, Y.H., J. Jayawardena, A. Weiss, D. Lee, S.H. Park, A. Dautry-
Varsat, and A. Bendelac. 1999. Distinct subsets of CD1d-restricted 
T cells recognize self-antigens loaded in diff  erent cellular compartments. 
J. Exp. Med. 189:103–110.
26. Brummelkamp, T.R., R. Bernards, and R. Agami. 2002. A system for 
stable expression of short interfering RNAs in mammalian cells. Science. 
296:550–553.
27. Benlagha, K., A. Weiss, A. Beavis, L. Teyton, and A. Bendelac. 2000. 
In vivo identifi  cation of glycolipid antigen-specifi  c T cells using fl  uores-
cent CD1d tetramers. J. Exp. Med. 191:1895–1903.
28. Zhou, D., J. Mattner, C. Cantu III, N. Schrantz, N. Yin, Y. Gao, Y. 
Sagiv, K. Hudspeth, Y.P. Wu, T. Yamashita, et al. 2004. Lysosomal 
glycosphingolipid recognition by NKT cells. Science. 306:1786–1789.
29. Bendelac, A., O. Lantz, M.E. Quimby, J.W. Yewdell, J.R. Bennink, 
and R.R. Brutkiewicz. 1995. CD1 recognition by mouse NK1+ 
T lymphocytes. Science. 268:863–865.